According to sources familiar with the matter, the Securities and Exchange Board of India has held back its green light for the much-awaited public issues so far, as share sales by these companies could have inadvertently ended up violating rules that govern unlisted companies.Read More
Zydus Lifesciences said it has received final approval from the US health regulator to manufacture a generic version of Apalutamide tablets used in the treatment of prostate cancerRead More
The NSE Nifty surged 325.55 points, or 1.45%, to close at 22,834.30. The BSE Sensex rose 1131.31 points, or 1.53%, to end at 75,301.26. Both indices have risen about 2% in the last two days.Read More
IndusInd Bank promoters reaffirm their commitment to the bank, viewing its depressed stock value as a strategic investment opportunity. Despite a 50% drop in six months, no fresh capital infusion is required. Hinduja Group holds a 16.29% stake, with 50.8% pledged.Read More
Foreign Institutional Investors (FIIs) bought Indian equities worth ₹694.57 crore on Tuesday, their first net purchase since February 19. Along with Domestic Institutional Investors (DIIs) buying ₹2,534.75 crore, this institutional inflow boosted Nifty and Sensex, which closed with significant gains.Read More
The Reserve Bank of India has announced a fresh open market operation to purchase government securities worth Rs 50000 crore on March 25 to ease the market liquidity condition.Read More
Amid market volatility, nine ET 500 companies, including Dixon Technologies, Zomato, and Suzlon, have exceeded FY24 revenue and profit levels in nine months of FY25, demonstrating strong financial performance despite uncertain demand.Read More
The Indian rupee gained 23 paise, closing at Rs 86.57 against the dollar, its highest in over three weeks, supported by dollar inflows and exporter sales. Strong economic data, foreign fund inflows, and a weaker dollar index contributed to the rise, while RBI intervened to rebuild forex reserves.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
